DEA Proposes Registration Fee Increases To Fund Diversion Control Program
This article was originally published in The Tan Sheet
Executive Summary
Non-retail distributors of pseudoephedrine, phenylpropanolamine and combination ephedrine products would be required to pay the full amount of Drug Enforcement Administration registration fees, under a proposed rule published in the Federal Register Nov. 16